However, the occurrence of the AD-like symptoms has been shown to be independent of IL-13/IL-4 and STAT6 (9, 10, 30), suggesting that IL-13 is involved in the molecular signature, rather than the skin symptom presence, of the in vivo AD model. This evidence concerns the gene IL4 and Alzheimer disease.